Timolol Maleate

規格

26921-17-5CAS番号

262-251-4EC番号

(Z)-but-2-enedioic acid;(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-olIUPAC名

C17H28N4O7S化学式

432.5 g/mol分子量

Timolol maleate; 26921-17-5; Istalol; Timoptic-XE; Timoptic in Ocudose; Aquanil; Ophtamolol; Timolol (as maleate); Timololi maleas; Timolol hydrogen maleate salt; Timolol maleate, s-enantiomer; wp-934; P8Y54F701R; NSC-757351; CHEBI:9600; (-)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)-2-propanol maleate (1:1) (salt); 2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)-, (Z)-2-butenedioate (1:1) (salt); DUOTRAV COMPONENT TIMOLOL MALEATE; GANFORT COMPONENT TIMOLOL MALEATE; XALACOM COMPONENT TIMOLOL MALEATE; Timolol GFS; Timoptic Xe; RefChem:56550; Timolol Maleate Ophthalmic; Timolol Maleate, (1:1) Salt; timolol maleate ophthalmic gel forming; Timolol Maleate Ophthalmic Gel Forming Solution; Timolol Maleate Ophthalmic Gel Forming Solution 0.5%; Timolol Maleate Ophthalmic Gel Forming Solution 0.25%; Timolol Maleate Ophthalmic Gel Forming Solution, 0.25%; Timolol Maleate Ophthalmic Gel Forming Solution, 0.5%; (2S)-1-((1,1-Dimethylethyl)amino)-3-(4-morpholin-4-yl-1,2,5-thiadiazol-3-yloxy)propan-2-ol monomaleate; (S)-Timolol maleate; Timolol maleate salt; Blocadren; Timoptic; Timolol hydrogen maleate; (S)-Timolol hydrogen maleate; (S)-Timolol (Maleate); MFCD00058356; DTXSID3047504; Timolol hydrogenmaleate; MLS000028539; 60469-65-0; (S)-(-)-Timolol Maleate; (-)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)-2-propanol maleate; (Z)-but-2-enedioic acid;(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol; SMR000058305; Timacor; Betime; l-Timolol maleate; C17H28N4O7S; (S)-1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol maleate; CCRIS 1057; (S)-3-(3-(tert-Butylamino)-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole monomaleate; EINECS 248-111-5; MK 950; CAS-26921-17-5; Optimol; UNII-P8Y54F701R; Blocadren;; Timoptic;; Timoptol;; Betimol;; Istalol;; Betime;; S-Timolol maleate; Blocadren (TN); Timolol maleate [USAN:USP:JAN]; Timolol maleate RS; Timoptic (TN); 50929-98-1; EINECS 262-251-4; Istalol (TN); Timolol maleate CRS; Bimatoprost / timolol; Opera_ID_1256; SCHEMBL26233; MLS001076135; orb342096; TIMOLOL MALEATE [JAN]; Timolol maleate (JP17/USP); TIMOLOL MALEATE [USAN]; orb3029223; TIMOLOL MALEATE [VANDF]; CHEMBL1200870; DTXCID1027504; TIMOLOL MALEATE [MART.]; TIMOLOL MALEATE [USP-RS]; TIMOLOL MALEATE [WHO-DD]; TIMOLOL MALEATE [WHO-IP]; HMS1570N18; HMS2097N18; HMS2230N19; HMS2234F03; HMS3411M12; HMS3675M12; HMS3714N18; HMS3885L05; Timolol for system suitability CRS; (S)-Timolol (maleate) (Standard); MSK10073; Tox21_302468; EBC-13256; HY-17380R; TIMOLOL MALEATE [ORANGE BOOK]; AKOS024458595; S-Timolol maleate - Bio-X trade mark; TIMOLOL MALEATE [EP MONOGRAPH]; TIMOLOL MALEATE [USP IMPURITY]; CCG-220948; COSOPT COMPONENT TIMOLOL MALEATE; FB63311; NSC 757351; TIMOLOL MALEATE [USP MONOGRAPH]; TIMOLOLI MALEAS [WHO-IP LATIN]; (S)-3-(3-(tert-bUtylamino)-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole maleate; S-(-)-1-(t-Butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-2-propanol maleate salt; COMBIGAN COMPONENT TIMOLOL MALEATE; NCGC00256737-01; 2-Propanol, 1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)-, (-)-, maleate (1:1) (salt); 2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-, (2S)-, (2Z)-2-butenedioate (1:1) (salt); AS-18090; BS164420; DA-48870; HY-17380; SMR000653470; SY284912; TIMOLOL HYDROGEN MALEATE SALT [MI]; NS00084740; Timolol maleate salt, >=98% (TLC), powder; D00603; F20622; TIMOLOL MALEATE, S-ENANTIOMER [WHO-DD]; EN300-21680303; SR-01000003102; SR-01000003102-3; Q27108445; Timolol Maleate 1.0 mg/ml in Methanol (as free base); Timolol maleate, British Pharmacopoeia (BP) Reference Standard; Timolol maleate, European Pharmacopoeia (EP) Reference Standard; Timolol maleate, United States Pharmacopeia (USP) Reference Standard; (S)-1-tert-Butylamino-3-(4-morpholin-4-yl-[1,2,5]thiadiazol-3-yloxy)-propan-2-ol maleate; Timolol for system suitability, European Pharmacopoeia (EP) Reference Standard; (2S)-1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol;maleic acid; (2S)-1-(tert-butylamino)-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propan-2-ol (2Z)-but-2-enedioate; (2S)-1-(tert-butylamino)-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propan-2-ol; (2Z)-but-2-enedioic acid; (2Z)-But-2-enedioic acid--(2S)-1-(tert-butylamino)-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propan-2-ol (1/1)別名